Australia's most trusted
source of pharma news
Saturday, 21 December 2024
Posted 17 December 2024 PM
Just a few weeks out from the New Year, Kathryn Evans has left her role as Managing Director of BioMarin to take up a new position as General Manager, Australia for global immunology company argenx.
It's a big move for Evans who finished up at BioMarin yesterday (Monday) after more than 12 years with the company.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.